INSP (Inspire Medical Systems, Inc.) Stock Analysis - SEC Filings

Inspire Medical Systems, Inc. (INSP) is a publicly traded Healthcare sector company. As of May 21, 2026, INSP trades at $44.14 with a market cap of $1.21B and a P/E ratio of 9.83. INSP moved +3.76% today. Year to date, INSP is -53.42%; over the trailing twelve months it is -70.58%. Its 52-week range spans $39.61 to $216.01. Analyst consensus is neutral with an average price target of $54.36. Rallies surfaces INSP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find INSP SEC filings?

Rallies organizes INSP SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

INSP Key Metrics

Key financial metrics for INSP
MetricValue
Price$44.14
Market Cap$1.21B
P/E Ratio9.83
EPS$4.46
Dividend Yield0.00%
52-Week High$216.01
52-Week Low$39.61
Volume0
Avg Volume0
Revenue (TTM)$915.25M
Net Income$131.14M
Gross Margin85.78%

Latest INSP News

Recent INSP Insider Trades

  • Rondoni John sold 109 (~$10.90K) on Jan 9, 2026.
  • mcCormick Shawn sold 1.20K (~$166.80K) on Dec 2, 2025.
  • mcCormick Shawn sold 2.00K (~$254.96K) on Nov 28, 2025.

INSP Analyst Consensus

13 analysts cover INSP: 0 strong buy, 3 buy, 10 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $54.36.

Common questions about INSP

Where can I find INSP SEC filings?
Rallies organizes INSP SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show INSP 10-K and 10-Q filings?
Rallies organizes INSP SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is INSP research on Rallies investment advice?
No. Rallies provides research, data, and educational context for INSP. It does not provide personalized investment advice.
INSP

INSP